Lin Zengfeng – Trademark Portfolio

Entity Type: 01

Lin Zengfeng holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 8 filings in this category. Currently, 8 trademarks are registered. Notable registered marks include SNBLK, ALLEUO, AULOFE, ALOBIMY, and AUROTLU. The owner is based in Shenzhen.

No.9 Dongwu Alley, Dapeng Villa

Dapeng New Dist, Shenzhen

Shenzhen 518000 , CN

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AUROTLU
AUROTLU
Registered 2020
ALOBIMY
ALOBIMY
Registered 2020
ALLEUO
ALLEUO
Registered 2020
AULOFE
AULOFE
Registered 2020
FULENCU
FULENCU
Registered 2020
SNBLK
SNBLK
Registered 2019
CHIMWAY
CHIMWAY
Registered 2018
DRACOOL
DRACOOL
Registered 2018

Trademark Classifications

Lin Zengfeng's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (8 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Lin Zengfeng have?

Lin Zengfeng has 8 U.S. trademarks filed with the USPTO. Of these, 8 registered.

What trademark classes does Lin Zengfeng file in?

Lin Zengfeng files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Lin Zengfeng's most well-known trademarks?

Lin Zengfeng's registered trademark portfolio includes well-known marks such as SNBLK, ALLEUO, AULOFE, ALOBIMY, and AUROTLU. These are among 8 currently registered trademarks in the portfolio.

What is Lin Zengfeng's trademark registration success rate?

Lin Zengfeng has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.